[VSsupport]

<img alt="" height="1" width="1" />Tioga Nabs $18M from VCs for Phase III Irritable Bowel StudiesBioWorld OnlineThat trial, scheduled to kick off next month, will enroll 600 D-IBS patients for twice daily treatment with 0.5 mg of asimadoline or placebo. ...San Diego's Tioga Pharmaceuticals Raises $18 Million to Develop IBS Drug<nobr>Xconomy</nobr>Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial ...<nobr>MarketWatch (press release)</nobr>Tioga Pharmaceuticals Raises $18M<nobr>San Diego Business Journal</nobr><nobr>FierceBiotech</nobr> -<nobr>socalTech.com</nobr><nobr>all 18 news articles »</nobr>

View the full article